A multicentre randomised and comparative trial to assess the tolerance, efficacy and pharmacokinetics of escalating doses of Casodex versus castration in the treatment of advanced carcinoma of the prostate
Latest Information Update: 21 Sep 2006
Price :
$35 *
At a glance
- Drugs Bicalutamide (Primary) ; Goserelin
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors AstraZeneca
- 21 Sep 2006 Status change
- 29 Nov 2005 New trial record.